Á lódáil...
Current status of intralesional agents in treatment of malignant melanoma
Prognosis of metastatic melanoma has undergone substantial improvement with the discovery of checkpoint inhibitors. Immunotherapies and targeted therapies have improved the median overall survival (OS) of metastatic melanoma from 6 months to more than 3 years. However, still about half of the patien...
Na minha lista:
| Foilsithe in: | Ann Transl Med |
|---|---|
| Main Authors: | , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
AME Publishing Company
2021
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8267328/ https://ncbi.nlm.nih.gov/pubmed/34277838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-21-491 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|